Table 1 Baseline data of studied patients
Variable | Total (n = 201) | CKD (n = 108) | Non- CKD (n = 93) | P-value |
|---|---|---|---|---|
Age in years (mean ± SD) | 57.58 ± 9.1 | 60.02 ± 9.1 | 55.33 ± 8.5 | < 0.001 |
Sex; male (%) | 116 (57.7) | 63 (58.3) | 53 (57) | 0.847 |
Smoking (%) | 83 (41.3) | 41 (38) | 42 (45.2) | 0.301 |
Duration of HTN in years (mean ± SD) | 6.87 ± 5.1 | 7.56 ± 5.9 | 6.05 ± 5.8 | 0.020 |
Anti-HTN Treatment: | Â | Â | Â | 0.001 |
RAAS-containing (%) | 116 (57.7) | 48 (46.6) | 68 (69.4) | |
Non RAAS-containing (%) | 85 (42.3) | 55 (53.4) | 30 (30.6) | |
Central SBP (mean ± SD) | 112.74 ± 18.83 | 112.28 ± 21.22 | 113.22 ± 16.03 | 0.72 |
Central DBP (mean ± SD) | 76.17 ± 14.61 | 75.91 ± 16.11 | 76.44 ± 12.94 | 0.79 |
Central pulse pressure (mean ± SD) | 36.96 ± 10.91 | 36.5 ± 11.19 | 37.44 ± 10.64 | 0.54 |
Automated SBP (mean ± SD) | 127.58 ± 20.86 | 126.04 ± 22.74 | 129.2 ± 18.65 | 0.28 |
Automated DBP (mean ± SD) | 76.55 ± 13.33 | 76.9 ± 14.32 | 76.18 ± 12.26 | 0.70 |
Automated pulse pressure (mean ± SD) | 50.8 ± 15.47 | 49.02 ± 14.67 | 52.67 ± 16.13 | 0.09 |
Augmentation index | 21.73 ± 12.0 | 24.06 ± 12.6 | 19.02 ± 10.8 | < 0.001 |
PWV | 8.86 ± 4.7 | 8.66 ± 1.5 | 8.69 ± 6.8 | 0.004 |
BMI (Kg/m2) (mean ± SD) | 28.84 ± 4.5 | 29.16 ± 4.7 | 28.46 ± 4.2 | 0.268 |